Ms. Groll leads product direction, operational execution and adoption strategy for Nabla’s AI platform, now used by over 85,000 clinicians across 130 organizations and supporting more than 20 million encounters annually. She designed a physician-led adoption model that bypasses procurement delays, enabling immediate clinical use and driving systemwide rollouts at institutions such as Denver Health and University of Iowa Health Care in Iowa City. Under her leadership, the platform expanded to 35 languages, incorporated safeguards against gender bias, and implemented accuracy and reliability systems that measure performance and reduce hallucination risk. In 2025, she directed operational strategy for Nabla’s $70 million Series C funding round, securing resources for expansion into nursing and inpatient care tools and advancing development toward a screenless, agentic AI model. Her work has improved documentation, coding and EHR workflows, delivering measurable gains in efficiency, clinician satisfaction and financial return. Committed to equity in leadership, she has built a leadership team that is 55% women. She also mentors early-stage founders and promotes women in senior technical roles.
